Search results
Showing 7576 to 7590 of 8942 results
Percutaneous radiofrequency ablation for renal cancer (IPG353)
We have moved interventional procedures guidance 353 to become HealthTech guidance 226. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Interventional procedures, IPG34 - Issued: December 2003 --> We have moved interventional procedures guidance 34 to become HealthTech guidance 15. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Arteriovenous crossing sheathotomy for branch retinal vein occlusion (IPG334)
Interventional procedures, IPG334 - Issued: March 2010 --> We have moved interventional procedures guidance 334 to become HealthTech guidance 211. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Interventional procedures, IPG347 - Issued: May 2010 --> We have moved interventional procedures guidance 347 to become HealthTech guidance 221. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Interventional procedures, IPG354 - Issued: July 2010 --> We have moved interventional procedures guidance 354 to become HealthTech guidance 227. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Macular translocation with 360° retinotomy for wet age-related macular degeneration (IPG340)
We have moved interventional procedures guidance 340 to become HealthTech guidance 216. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Extracranial to intracranial bypass for intracranial atherosclerosis (IPG348)
This guidance has been updated and replaced by NICE interventional procedures guidance 596.
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia (IPG355)
Interventional procedures, IPG355 - Issued: September 2010 --> We have moved interventional procedures guidance 355 to become HealthTech guidance 228. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE HealthTech guidance 603.
October 2018: This process guide has been updated. The updated version can be found in the tools and resources for developing NICE guidelines: the manual.
Process manual for the endorsement of guidance and quality standard support resources (PMG29)
The endorsement programme is now closed and no new applications are being accepted. Information about existing endorsed resources, are available on the endorsement webpage. Please email endorsement@nice.org.uk if you have any queries.
Medicines optimisation: key therapeutic topics – Integrated process statement (PMG13)
February 2022: we have withdrawn our medicines optimisation: key therapeutic topics. We have taken this decision after reviewing the wide range of services we currently provide, so we can focus on delivering the priorities outlined in our 5-year strategy. If you have any queries, please contact nice@nice.org.uk.
Process guide for adoption support resources for health technologies (PMG23)
This process and methods guide has been withdrawn.
Medical technologies evaluation programme methods guide (PMG33)
This medical technologies evaluation programme methods guide has been replaced by the NICE HealthTech programme manual.
This guide has been updated and replaced by practical steps to improving the quality of care and services using NICE guidance.